ARCHIVES

European regulators plan more rigorous rules for accelerated approval in cancer.

This article is from The Cancer Letter archive.

Vol. 31 No. 41 | November 11, 2005

Download PDF Visit The Full Archive

Related Articles

Clinical Trials: Data Manager Falsified NSABP Records On 3 Patients, ORI Says

February 12, 1999

Aromasin Approved By FDA For ER+ Early Breast Cancer

October 28, 2005

Cancer Prevention: NSABP Publishes P-1 Data, Finds Risk Of Breast Cancer Cut By 49 Percent

September 18, 1998

Cancer Clinical Trials Approved By NCI Last Month Are Listed

November 29, 2002

Scientists Defend NCI, Criticize Post Series As Inaccurate

November 20, 1981

Medicare plans to cut oncology payments on Jan. 1 unless Congress intervenes.

October 17, 2003